Skip to main content
Clinical Trials/JPRN-UMIN000009264
JPRN-UMIN000009264
Completed
未知

The evaluation of symptom and pathophysiological changes after 20mg of esomeprazole administration by 24-hour intraesophageal pH/impedance (MII-pH) monitoring. - The evaluation of symptom and pathophysiological changes after esomeprazole administration by impedance monitoring.

Division of Gastroenterology, Aichi Medical University School of Medicine0 sites40 target enrollmentNovember 10, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
PPI-resistant gastro-esophageal reflux disease
Sponsor
Division of Gastroenterology, Aichi Medical University School of Medicine
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2012
End Date
April 30, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Division of Gastroenterology, Aichi Medical University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)alarm sign such as vomitting or gastrointestinal bleeding (2\)Zollinger Ellison syndrome, esophageal stenosis, achalasia, cerebrovascular disorder (3\)Serious hepatic disorder, renal disease, heart disorder (4\)malignant disorder (5\)A pregnant woman, nursing mother or the woman who may be pregnant. (6\)In addition, clinical studies supervisor or the study attending physician judged the subject to be inadequate to attend this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials